Stocksigma LogoStocksigma Logo

Pfizer Discontinues Minipress XL; Receives Rs. 131.38 Crore Lump Sum From Parent

Pfizer Limited announced the immediate discontinuation of the marketing, distribution, and sale of Minipress XL effective 7th Sep'26, following a decision

Pfizer Discontinues Minipress XL; Receives Rs. 131.38 Crore Lump Sum From Parent

Pfizer Ltd 路 Others (Uncategorized) 路 07 Sept 2026, 4:54 pm

Pfizer Discontinues Minipress XL; Receives Rs. 131.38 Crore Lump Sum From Parent Pfizer Limited announced the immediate discontinuation of the marketing, distribution, and sale of Minipress XL effective 7th Sep'26, following a decision by parent entity Pfizer Inc. USA to stop manufacturing the drug. In connection with the discontinuation, the company will receive a one-time lump sum compensation of USD 13.9 million (~Rs. 131.38 Crore) from Pfizer Inc. USA.

Original exchange filing (PDF)

More announcements from Pfizer Ltd

All Pfizer Ltd announcements